Annual Working Capital
$52.23 M
-$809.00 K-1.53%
December 31, 2023
Summary
- As of February 7, 2025, ELDN annual working capital is $52.23 million, with the most recent change of -$809.00 thousand (-1.53%) on December 31, 2023.
- During the last 3 years, ELDN annual working capital has fallen by -$60.91 million (-53.84%).
- ELDN annual working capital is now -53.84% below its all-time high of $113.15 million, reached on December 31, 2020.
Performance
ELDN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$69.02 M
-$12.18 M-15.00%
September 30, 2024
Summary
- As of February 7, 2025, ELDN quarterly working capital is $69.02 million, with the most recent change of -$12.18 million (-15.00%) on September 30, 2024.
- Over the past year, ELDN quarterly working capital has increased by +$8.93 million (+14.86%).
- ELDN quarterly working capital is now -39.00% below its all-time high of $113.15 million, reached on December 31, 2020.
Performance
ELDN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ELDN Working Capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -1.5% | +14.9% |
3 y3 years | -53.8% | +14.9% |
5 y5 years | +344.9% | +14.9% |
ELDN Working Capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -37.8% | at low | -17.8% | +58.9% |
5 y | 5-year | -53.8% | +503.9% | -39.0% | +698.0% |
alltime | all time | -53.8% | +2000.8% | -39.0% | +2611.6% |
Eledon Pharmaceuticals Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $69.02 M(-15.0%) |
Jun 2024 | - | $81.20 M(+85.7%) |
Mar 2024 | - | $43.73 M(-16.3%) |
Dec 2023 | $52.23 M(-1.5%) | $52.23 M(-13.1%) |
Sep 2023 | - | $60.09 M(-12.6%) |
Jun 2023 | - | $68.72 M(+58.3%) |
Mar 2023 | - | $43.43 M(-18.1%) |
Dec 2022 | $53.04 M(-36.8%) | $53.04 M(-13.4%) |
Sep 2022 | - | $61.28 M(-11.8%) |
Jun 2022 | - | $69.51 M(-9.0%) |
Mar 2022 | - | $76.37 M(-9.0%) |
Dec 2021 | $83.94 M(-25.8%) | $83.94 M(-8.3%) |
Sep 2021 | - | $91.51 M(-8.4%) |
Jun 2021 | - | $99.91 M(-5.8%) |
Mar 2021 | - | $106.03 M(-6.3%) |
Dec 2020 | $113.15 M(+1208.2%) | $113.15 M(+3.8%) |
Sep 2020 | - | $108.97 M(+1157.7%) |
Jun 2020 | - | $8.66 M(-21.2%) |
Mar 2020 | - | $10.99 M(+27.1%) |
Dec 2019 | $8.65 M | $8.65 M(-18.7%) |
Sep 2019 | - | $10.63 M(-19.6%) |
Jun 2019 | - | $13.23 M(+86.9%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $7.08 M(-39.7%) |
Dec 2018 | $11.74 M(-33.1%) | $11.74 M(-24.3%) |
Sep 2018 | - | $15.51 M(-21.0%) |
Jun 2018 | - | $19.63 M(-12.4%) |
Mar 2018 | - | $22.41 M(+27.6%) |
Dec 2017 | $17.56 M(-739.0%) | $17.56 M(-6.2%) |
Sep 2017 | - | $18.73 M(-13.6%) |
Jun 2017 | - | $21.68 M(-6.6%) |
Mar 2017 | - | $23.21 M(-944.7%) |
Dec 2016 | -$2.75 M(-104.5%) | -$2.75 M(-109.2%) |
Sep 2016 | - | $29.99 M(-21.8%) |
Jun 2016 | - | $38.37 M(-24.5%) |
Mar 2016 | - | $50.81 M(-16.7%) |
Dec 2015 | $61.01 M(-40.9%) | $61.01 M(-14.3%) |
Sep 2015 | - | $71.21 M(-13.3%) |
Jun 2015 | - | $82.11 M(-9.3%) |
Mar 2015 | - | $90.58 M(-12.3%) |
Dec 2014 | $103.27 M(+244.6%) | $103.27 M(+1.9%) |
Sep 2014 | - | $101.35 M(+461.5%) |
Jun 2014 | - | $18.05 M(-39.8%) |
Dec 2013 | $29.97 M(+202.5%) | $29.97 M |
Dec 2012 | $9.91 M | - |
FAQ
- What is Eledon Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals annual working capital year-on-year change?
- What is Eledon Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Eledon Pharmaceuticals?
- What is Eledon Pharmaceuticals quarterly working capital year-on-year change?
What is Eledon Pharmaceuticals annual working capital?
The current annual working capital of ELDN is $52.23 M
What is the all time high annual working capital for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high annual working capital is $113.15 M
What is Eledon Pharmaceuticals annual working capital year-on-year change?
Over the past year, ELDN annual working capital has changed by -$809.00 K (-1.53%)
What is Eledon Pharmaceuticals quarterly working capital?
The current quarterly working capital of ELDN is $69.02 M
What is the all time high quarterly working capital for Eledon Pharmaceuticals?
Eledon Pharmaceuticals all-time high quarterly working capital is $113.15 M
What is Eledon Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ELDN quarterly working capital has changed by +$8.93 M (+14.86%)